Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 92,000 | 144,400 | 77,781 | 261,538 | 91,323 |
| Depreciation Amortization | 97,000 | 166,600 | 72,863 | 23,141 | 13,756 |
| Income taxes - deferred | 29,000 | 395,500 | 385,915 | -3,565 | -24,823 |
| Accounts receivable | -37,000 | -115,800 | -90,952 | -108,984 | -58,918 |
| Other Working Capital | -90,000 | -415,200 | -334,000 | -130,575 | -62,504 |
| Other Operating Activity | 83,000 | 499,700 | 372,735 | 219,701 | 64,200 |
| Operating Cash Flow | $174,000 | $675,200 | $484,342 | $261,256 | $23,034 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 58,000 | 635,000 | 716,469 | 839,640 | 7,701 |
| PPE Investments | -64,000 | -286,300 | -206,224 | -130,171 | -57,075 |
| Net Acquisitions | N/A | -3,939,300 | -3,939,307 | -3,939,268 | N/A |
| Other Investing Activity | 0 | 5,400 | 5,479 | 1,410 | 951 |
| Investing Cash Flow | $-6,000 | $-3,585,200 | $-3,423,583 | $-3,228,389 | $-48,423 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 200,000 | 200,000 | 200,000 | N/A |
| Debt Issued | N/A | 3,500,000 | 3,500,000 | 3,500,000 | N/A |
| Debt Repayment | -175,000 | -101,200 | -57,500 | -57,500 | -12,000 |
| Common Stock Issued | 4,000 | 82,000 | 50,824 | 31,684 | 24,882 |
| Common Stock Repurchased | -297,000 | -327,700 | -175,383 | -83,563 | -60,026 |
| Other Financing Activity | -4,000 | -368,000 | -351,554 | -239,206 | 52,218 |
| Financing Cash Flow | $-472,000 | $2,985,100 | $3,166,387 | $3,351,415 | $5,074 |
| Exchange Rate Effect | 4,000 | -9,000 | -7,864 | -6,158 | -6,870 |
| Beginning Cash Position | 1,010,000 | 944,000 | 943,999 | 943,999 | 943,999 |
| End Cash Position | 710,000 | 1,010,100 | 1,163,281 | 1,322,123 | 916,814 |
| Net Cash Flow | $-300,000 | $66,100 | $219,282 | $378,124 | $-27,185 |
| Free Cash Flow | |||||
| Operating Cash Flow | 174,000 | 675,200 | 484,342 | 261,256 | 23,034 |
| Capital Expenditure | -64,000 | -286,300 | -206,224 | -130,171 | -57,075 |
| Free Cash Flow | 110,000 | 388,900 | 278,118 | 131,085 | -34,041 |